Clinical Trial Update: Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting results of a fixed-dose combination of umeclidinium/vilanterol with indacaterol plus tiotropium in COPD. The study is completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Anoro Ellipta (umeclidinium/vilanterol) (umeclidinium/vilanterol)
• Onbrez Breezhaler (indacaterol) (indacaterol)
• Spiriva (tiotropium) (tiotropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2016-03-03